Beta Blocker De-prescription Following Coronary Artery Bypass Graft Surgery (BEEFBURGER Trial).

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT04788186

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04788186
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04788186. Randomized; no masking; primary purpose treatment. Start 2021-08-23 (actual); primary completion 2024-08-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Beta Blocker De-prescription Following Coronary Artery Bypass Graft Surgery (BEEFBURGER Trial).
Acronym
BEEFBURGER
Condition
Acute Myocardial Infarction
Condition
Coronary Artery Stenosis
Condition
ST Elevation Myocardial Infarction
Condition
Non-ST Elevation Myocardial Infarction (NSTEMI)
Intervention (Drug)
De-prescribe beta blocker therapy
Lead sponsor
University of Saskatchewan (class: other)
Collaborator
Canadian VIGOUR Centre (class: other)

Record details

Record id
cardio:ct-nct04788186
Content hash
7dcd92e7abdfeab1f9083899ad13480dadc53cf3dbe56f854a8b0c45bc3d471b